Clinical Trial

PET Imaging CCR2 in Lung Inflammation

Study Description

PET Imaging CCR2 in Lung Inflammation

The primary objective of this study is to determine the safety of the novel probe 64Cu-DOTA-ECL1i for PET imaging of CCR2 expression.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - 64Cu-DOTA-ECL1i

Radiolabeled probe called 64Cu-DOTA-ECL1i that recognizes CCR2 and propose to image CCR2 in the lung to ultimately guide diagnosis and therapy.

Additional Information

Official Study Title

PET Imaging CCR2 in Lung Inflammation

Clinical Trial ID

NCT03492762

ParticipAid ID

vbmK3e